SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2025 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Thursday, August 14th, 2025 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | https://edge.media-server.com/mmc/p/tnombut6/ |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$1.71 |
| Daily Change: | 0.05 3.01 |
| Daily Volume: | 1,931,144 |
| Market Cap: | US$8.140M |
September 17, 2025 September 16, 2025 September 15, 2025 August 25, 2025 August 14, 2025 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
